| Overall (N=43) |
|
|---|---|
Data are presented as incidence (frequency) or mean (standard deviation) | |
| Age at implantation (years) | |
| Mean (SD) | 67 (12) |
| Gender | |
| Male | 20 (47 %) |
| Female | 23 (53 %) |
| Hearing preservation side | |
| right | 24 (56 %) |
| left | 19 (44 %) |
| CI ear | |
| Right | 20 (47 %) |
| Left | 11 (26 %) |
| Bilateral | 12 (28 %) |
| Preimplant Low-Frequency PTA (dB HL) | |
| Mean (SD) | 48 (13) |
| Postimplant Low-Frequency PTA (dB HL) | |
| Mean (SD) | 85 (20) |
| Electrode | |
| HiRes Ultra 3D | 10 (23 %) |
| Neuro Zti | 7 (16 %) |
| Nucleus® CI522 | 1 (2 %) |
| Nucleus® CI622 | 23 (53 %) |
| Nucleus® CI632 | 2 (5 %) |
| Intravenous dexamethasone | |
| No | 13 (30 %) |
| Yes | 30 (70 %) |
| Round window dexamethasone | |
| No | 22 (51 %) |
| Yes | 21 (49 %) |